The Global Fund Advocates Network Asia-Pacific (GFAN AP) is an advocacy platform of HIV, Tuberculosis and malaria community and civil society advocates in the Asia-Pacific region. We support advocacy for a fully resourced Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), increased and sustainable domestic resource mobilisation for health, and equitable, people, centred, human rights-based and gender transformative inclusion of HIV, TB and malaria responses within Universal Health Coverage (UHC).
What’s New
World AIDS Day 2024
This statement is jointly released by Global Fund Advocates Network Asia-Pacific (GFAN AP), communities and civil society across Asia-Pacific to call on leaders to ‘take the rights path’ towards ending AIDS as an epidemic. The promotion and upholding of human rights is not only a necessary obligation by leaders and duty-bearers, it is also an essential approach for ending AIDS as an epidemic, for ensuring sustainable development, and for safeguarding human security.
Unpacking the Global Fund Results Report 2024
The webinar was organised by Global Fund Advocates Network Asia-Pacific (GFAN AP) on 23rd October 2024 to bring together community and civil society partners from the Asia-Pacific to present on the key findings of the Global Fund Results Report 2024 (Results Report) and its impact on Asia-Pacific leading up to the Global Fund Eighth Replenishment. Click here for the recording and the blog summary to learn more on the key results from 2024 of the Global Fund.
World Mental Health Day 2024
This statement is jointly released by Global Fund Advocates Network Asia-Pacific (GFAN AP), United for Global Mental Health (UnitedGMH) and the Seven Alliance on World Mental Health Day 2024. As communities and civil society from the Asia-Pacific, we are reminded of the inseparable relationships between mental health, health systems, and access to gainful employment, especially as they have a compounding effect on key and vulnerable communities living with and/or affected by HIV, tuberculosis (TB) and malaria. Read more here.